Te Ahumairangi Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.04M | Buy |
249,046
+34,650
| +16% | +$840K | 1.08% | 29 |
|
|
2025
Q1 | $5.43M | Buy |
214,396
+14,973
| +8% | +$379K | 1.15% | 29 |
|
|
2024
Q4 | $5.29M | Sell |
199,423
-13,200
| -6% | -$350K | 1.11% | 28 |
|
|
2024
Q3 | $6.12M | Buy |
212,623
+11,000
| +5% | +$317K | 1.08% | 34 |
|
|
2024
Q2 | $5.64M | Sell |
201,623
-12,491
| -6% | -$349K | 1.08% | 36 |
|
|
2024
Q1 | $5.94M | Buy |
214,114
+14,190
| +7% | +$394K | 1.03% | 37 |
|
|
2023
Q4 | $5.76M | Sell |
199,924
-34,000
| -15% | -$979K | 1.09% | 36 |
|
|
2023
Q3 | $7.76M | Buy |
233,924
+6,780
| +3% | +$225K | 1.26% | 27 |
|
|
2023
Q2 | $8.33M | Buy |
227,144
+23,050
| +11% | +$846K | 1.14% | 34 |
|
|
2023
Q1 | $8.33M | Buy |
204,094
+34,975
| +21% | +$1.43M | 1.19% | 25 |
|
|
2022
Q4 | $8.67M | Sell |
169,119
-3,000
| -2% | -$154K | 1.36% | 24 |
|
|
2022
Q3 | $7.53M | Sell |
172,119
-3,485
| -2% | -$153K | 1.28% | 28 |
|
|
2022
Q2 | $9.21M | Sell |
175,604
-1,430
| -0.8% | -$75K | 1.39% | 24 |
|
|
2022
Q1 | $9.17M | Buy |
177,034
+14,205
| +9% | +$735K | 1.24% | 28 |
|
|
2021
Q4 | $9.62M | Buy |
162,829
+30,000
| +23% | +$1.77M | 1.24% | 29 |
|
|
2021
Q3 | $5.71M | Buy |
132,829
+11,000
| +9% | +$473K | 0.79% | 56 |
|
|
2021
Q2 | $4.77M | Buy |
121,829
+13,000
| +12% | +$509K | 0.62% | 70 |
|
|
2021
Q1 | $3.94M | Buy |
108,829
+57,000
| +110% | +$2.07M | 0.51% | 76 |
|
|
2020
Q4 | $1.91M | Buy |
51,829
+2,471
| +5% | +$91K | 0.27% | 97 |
|
|
2020
Q3 | $1.72M | Buy |
+49,358
| New | +$1.72M | 0.29% | 95 |
|